1. Home
  2. AEIS vs IOVA Comparison

AEIS vs IOVA Comparison

Compare AEIS & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AEIS
  • IOVA
  • Stock Information
  • Founded
  • AEIS 1981
  • IOVA 2007
  • Country
  • AEIS United States
  • IOVA United States
  • Employees
  • AEIS N/A
  • IOVA N/A
  • Industry
  • AEIS Industrial Machinery/Components
  • IOVA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • AEIS Technology
  • IOVA Health Care
  • Exchange
  • AEIS Nasdaq
  • IOVA Nasdaq
  • Market Cap
  • AEIS 4.3B
  • IOVA 2.6B
  • IPO Year
  • AEIS 1995
  • IOVA N/A
  • Fundamental
  • Price
  • AEIS $118.07
  • IOVA $5.89
  • Analyst Decision
  • AEIS Buy
  • IOVA Strong Buy
  • Analyst Count
  • AEIS 8
  • IOVA 9
  • Target Price
  • AEIS $125.25
  • IOVA $23.33
  • AVG Volume (30 Days)
  • AEIS 212.7K
  • IOVA 8.2M
  • Earning Date
  • AEIS 02-04-2025
  • IOVA 02-26-2025
  • Dividend Yield
  • AEIS 0.34%
  • IOVA N/A
  • EPS Growth
  • AEIS N/A
  • IOVA N/A
  • EPS
  • AEIS 1.13
  • IOVA N/A
  • Revenue
  • AEIS $1,471,910,000.00
  • IOVA $90,858,000.00
  • Revenue This Year
  • AEIS N/A
  • IOVA $13,758.71
  • Revenue Next Year
  • AEIS $11.81
  • IOVA $171.20
  • P/E Ratio
  • AEIS $103.99
  • IOVA N/A
  • Revenue Growth
  • AEIS N/A
  • IOVA 12751.20
  • 52 Week Low
  • AEIS $89.12
  • IOVA $5.77
  • 52 Week High
  • AEIS $128.70
  • IOVA $18.33
  • Technical
  • Relative Strength Index (RSI)
  • AEIS 51.88
  • IOVA 26.25
  • Support Level
  • AEIS $114.66
  • IOVA $5.77
  • Resistance Level
  • AEIS $128.70
  • IOVA $8.15
  • Average True Range (ATR)
  • AEIS 3.74
  • IOVA 0.44
  • MACD
  • AEIS -0.01
  • IOVA -0.11
  • Stochastic Oscillator
  • AEIS 37.14
  • IOVA 5.04

About AEIS Advanced Energy Industries Inc.

Advanced Energy Industries Inc provides precision power-conversion measurement and control solutions that transform power into various forms for use in manufacturing and industrial equipment and applications. The firm serves original equipment manufacturers and end customers in the semiconductor, flat panel display, solar panel, and other industrial capital equipment markets. Products include thin-film power-conversion systems, which control and modify raw electrical power into a customizable, predictable power source, and power control modules, which control and measure temperature during manufacturing cycles. A majority of the firm's revenue is generated in the United States, with the rest primarily from Asia and Europe.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

Share on Social Networks: